Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)

Clinical and Experimental Immunology

Volumn 103, Issue 3, 1996, Pages 391-396

  Bouma, G ^a   Xia, B ^a,b   Crusius, J B A ^a   Bioque, G ^a   Koutroubakis, I ^a,c   Von Blomberg, B M E ^a   Meuwissen, S G M ^a   Pena A S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WUHAN UNIVERSITY   (China)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Association; Crohn's disease; Gene polymorphism; Haplotype; HLA; Inflammatory bowel disease; Lymphotoxin ; Tumour necrosis factor alpha; Ulcerative colitis

Indexed keywords

AUTOANTIBODY; GRANULOCYTE ANTIBODY; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENETIC POLYMORPHISM; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0029965796     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1996.tb08292.x     Document Type: Article

References (31)

1. Peña AS, Crusius JBA, Oudkerk Pool M et al. Genetics and epidemiology may contribute to understanding the pathogenesis of IBD - a new approach is now indicated. Can J Gastroenterol 1993; 7:71-75.
2. Koutroubakis I, Peña AS. Genetics of inflammatory bowel disease. In: Allan RN, Keighley MRB, Alexander-Williams J, Fazio VW, Hanauer S, Rhodes JM, eds. Inflammatory bowel disease, 3rd edn. London: Churchill Livingstone, 1996; in press.
3. Freidel AC, Betuel H, Gebuhrer L, Farre A, Lambert J. Cellular and serological subtypes of HLA-DR2. Tissue Antigens 1987; 29:129-40.
4. Toyoda H, Wang SJ, Yang HY et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104:741-8.
5. Sugimura K, Asakura H, Mizuki M et al Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol 1993; 36:112-8.
6. Masuda H, Nakamura Y, Tanaka T, Hayakawa S. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis. Am J Gastroenterol 1994; 89:1957-62.
7. Futami S, Aoyama N, Honsako Y et al. HLA-DRB1-*-1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis. Dig Dis Sci 1995; 40:814-8.
8. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an anti-neutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995; 108:423-7.
9. Colombel JF, Danze PM, Jacquot S et al. HLA class II genes and Crohn's disease: different associations in adults and children. Gastroenterology 1995; 108:A800.
10. Jacob CO. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunol Today 1992; 13:122-5.
11. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87:1233-7.
12. Messer G, Spengler U, Jung MC et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: a NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173:209-19.
13. Pociot F, Molvig J, Wogensen L et al. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991; 33:37-49.
14. Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23:224-31.
15. Ferencik S, Lindemann M, Horsthemke B, Grosse-Wilde H. A new restriction fragment length polymorphism of the human TNF-beta gene detected by AspHI digest. Eur J Immunogenetics 1992; 19:425-30.
16. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor (TNF) alpha gene detectable by NcoI restriction of PCR product. Hum Mol Gen 1992; 1:353.
17. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW, An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177:557-60.
18. D'Alfonso S, Momigliano Richiardi P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39:150-4.
19. Crusius JBA, Bing X, Mulder CJJ, Mearin ML, Peña AS. Relevance of haplotypes in the TNF region in celiac disease. Eur Cytokine Network 1994; 5:168.
20. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86:202-10.
21. Oudkerk Pool M, Ellerbroek P, Ridwan B et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993; 34:46-50.
22. Shanahan F, Duerr RH, Rotter JI et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992; 103:456-61.
23. Yang H, Rotter JI, Toyoda H et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA Class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993; 92:1080-4.
24. Koutroubakis I, Xia B, Crusius JBA et al. Tumor necrosis factor alpha polymorphism in inflammatory bowel disease. Hellenic J Gastroenterol 1995; 8:132-5.
25. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 24 (Suppl. 170):2-6.
26. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97:12-13.
27. Salsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994; 35:696-700.
28. Sachar DB, Andrews HA, Farmer RG et al. Proposed classification of patients subgroups in Crohn's disease. Working team report. Gastroenterol Int 1992; 5:141-54.
29. Peña AS, Meuwissen SGM. Clinical subgroups in inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins, 1994: 272-8.
30. Bouma G, Oudkerk Pool M, Scharenberg JGM et al. Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce the cytokines tumour necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls. Scand J Gastroenterol 1995; 30:1095-100.
31. Bouma G, Crusius JBA, Oudkerk Pool M et al. Haplotype restricted differences in in vitro production of tumor necrosis factor alpha and lymphotoxin alpha in patients with inflammatory bowel disease and healthy controls. Gastroenterology 1995; 108:A787.